Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Mt khc, mt s nn vn ha chu , nc da trng thng c a chung hn, tng trng cho s chm ch, a v cao, v.v
Rosca MG, Lemieux H, Hoppel CL
$313.00 5 in stock 5 in stock CJC-1295 No DAC (10mg) + Ipamorelin Blend (10mg) adds two well-researched growth hormone secretagogues in an equal ratio, i.e., 1:1
AOD-9604 Supplies Needed Plan based on subcutaneous research dosing of 300-500 mcg/day from a 5 mg vial reconstituted with 3.0 mL bacteriostatic water
The Rewind Protocol Consultation & Blood Work Baseline labs including IGF-1, comprehensive metabolic panel, and relevant markers to confirm growth hormone optimization is appropriate
Synthetic Lipolytic Domain Characterization Ng et al., Hormone Research (2000) Ng and colleagues conducted foundational characterization studies of the AOD-9604 synthetic lipolytic domain using a combination of in vitro adipocyte assays and in vivo obese Zucker rat models
